MRD (NGS) results after induction, ASCT, and consolidation
| Patients . | MRD level . | Post-induction . | Post-ASCT . | Post-consolidation . |
|---|---|---|---|---|
| ITT (n = 18) | <10−5 | 2/18 (11%) | 10/18 (56%) | 8/18 (44%) |
| <10−6 | 1/18 (6%) | 3/18 (17%) | 3/18 (17%) | |
| Evaluable* (n = 12) | <10−5 | 2/12 (15%) | 10/12 (83%) | 8/12 (67%) |
| <10−6 | 1/12 (8%) | 3/12 (25%) | 3/12 (25%) |
| Patients . | MRD level . | Post-induction . | Post-ASCT . | Post-consolidation . |
|---|---|---|---|---|
| ITT (n = 18) | <10−5 | 2/18 (11%) | 10/18 (56%) | 8/18 (44%) |
| <10−6 | 1/18 (6%) | 3/18 (17%) | 3/18 (17%) | |
| Evaluable* (n = 12) | <10−5 | 2/12 (15%) | 10/12 (83%) | 8/12 (67%) |
| <10−6 | 1/12 (8%) | 3/12 (25%) | 3/12 (25%) |
ITT, intention-to-treat.
Patients who achieved ≥ VGPR after completion of ASCT and with MRD results available.